Know Cancer

or
forgot password

A Phase I Study of Tomotherapy in Patients With Benign Brain Tumour


Phase 1
18 Years
65 Years
Open (Enrolling)
Both
Brain Neoplasms

Thank you

Trial Information

A Phase I Study of Tomotherapy in Patients With Benign Brain Tumour


Inclusion Criteria:



- Histopathologically confirmed newly diagnosed base of skull benign tumour

- Karnofsky Performance Status (KPS) equal to or greater than 70

Exclusion Criteria:

- Brain metastases or recurrent tumour

- Prior radiotherapy (RT) to head or neck

- No prior chemotherapy or radiosensitizer

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

safety and adverse effects

Outcome Time Frame:

Trial Completion

Safety Issue:

Yes

Principal Investigator

Wilson Roa, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Alberta Health Services

Authority:

Canada: Health Canada

Study ID:

CNS-09-0029 / ethics 21879

NCT ID:

NCT00128986

Start Date:

May 2005

Completion Date:

July 2012

Related Keywords:

  • Brain Neoplasms
  • radiotherapy
  • brain
  • Brain Neoplasms
  • Neoplasms

Name

Location